Ascletis Receives $100,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5e08c734-f674-4199-aefa-c4ca784a4c3d - Date
1/5/2017 - Company Name
Ascletis - Mailing Address
1002 Northridge Lane Chapel Hill, NC 27514 USA - Company Description
Ascletis focuses on building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. - Website
http://www.ascletis.com - Transaction Type
Venture Equity - Transaction Amount
$100,000,000 - Transaction Round
Series B - Proceeds Purposes
Ascletis plans to use the proceeds from this financing to expand its product portfolio and sales force. - M&A Terms
- Venture Investor
C-Bridge Capital - Venture Investor
Focus Ventures - Venture Investor
Goldman Sachs - Venture Investor
Undisclosed
